AACR Journal Cancer Discovery Celebrates 10th Anniversary with Virtual Symposium Highlighting Emerging Areas of Cancer Research
Complimentary registration is available to credentialed news media
Later this month, the American Association for Cancer Research (AACR) will host the Cancer Discovery 10th Anniversary Symposium: The Next Decade of Discoveries. This virtual meeting will celebrate the 10th anniversary of the launch of the AACR journal Cancer Discovery and feature presentations from key thought leaders on areas of cancer research that will significantly move the field forward in the next 10 years.
June 21-22, 2021
12-5 p.m. ET
This meeting will be presented virtually via myAACR. Registration is complimentary for credentialed news media and includes access to both the live sessions and the on-demand recording. Please review the registration requirements and policies. Members of the media can register by filling out the registration form in the AACR’s online newsroom. Contact Kathleen Venango at [email protected] or 215-290-5408 with any questions about the registration process.
The program will be moderated by the Editors-in-Chief of Cancer Discovery, Lewis C. Cantley, PhD, FAACR, and Luis A. Diaz Jr., MD. World-renowned cancer researchers will present on topics including diet and the role it plays in cancer prevention and treatment; aging and cancer; microbiota-centered interventions for immune-oncology; deciphering and targeting clonal hematopoiesis; the future of AI-based risk assessment models; precision medicine in cancer care; clinical trial design; and resistance to targeted therapy. There will be a Q&A session after each talk and a panel discussion at the end of each day.
Moderators and speakers include:
- Margaret Foti, PhD, MD (hc), chief executive officer, AACR, Philadelphia
- Lewis C. Cantley, PhD, FAACR, editor-in-chief, Cancer Discovery; Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College and NewYork-Presbyterian Hospital, New York
- Luis A. Diaz Jr., MD, editor-in-chief, Cancer Discovery, and member of the AACR Board of Directors; Memorial Sloan Kettering Cancer Center, New York
- Ira Mellman, PhD, member of the AACR Board of Directors; Genentech Inc., San Francisco
- Ashani T. Weeraratna, PhD, Johns Hopkins University, Baltimore
- Laurence Zitvogel, MD, PhD, Gustave Roussy, Villejuif, France
- Ross Levine, MD, Memorial Sloan Kettering Cancer Center, New York
- Regina Barzilay, PhD, Massachusetts Institute of Technology, Cambridge
- Tony S.K. Mok, MD, Chinese University of Hong Kong, Shatin, Hong Kong
- Katherine Janeway, MD, MMSc, Dana–Farber Cancer Institute, Boston
- Alice T. Shaw, MD, PhD, Novartis, Boston
View the full program.